<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01237613</url>
  </required_header>
  <id_info>
    <org_study_id>KP027ext</org_study_id>
    <nct_id>NCT01237613</nct_id>
  </id_info>
  <brief_title>Prospective Study on Artelon® Tissue Reinforcement in Repair of Chronic Ruptures and Re-ruptures of the Achilles Tendon</brief_title>
  <official_title>Prospective Study on Artelon® Tissue Reinforcement in Repair of Chronic Ruptures and Re-ruptures of the Achilles Tendon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthopedic Foot and Ankle Center, Ohio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Artimplant AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Orthopedic Foot and Ankle Center, Ohio</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the surgical and clinical outcome of Artelon® Tissue
      Reinforcement in repair of chronic ruptures or re-ruptures of the Achilles tendon, with
      regard to lower leg and foot function, pain and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsoring company declared bankrupty
  </why_stopped>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion, Strength and Calf Circumference</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Evaluation of Treatment</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to Work and Previous Physical Activities</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Evaluation Including Adverse Events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion, Strength and Calf Circumference</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Evaluation of Treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to Work and Previous Physical Activities</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Evaluation Including Adverse Events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of Motion, Strength and Calf Circumference</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Evaluation of Treatment</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to Work and Previous Physical Activities</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Evaluation Including Adverse Events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Achilles Tendon Rupture</condition>
  <arm_group>
    <arm_group_label>Artelon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Artelon</intervention_name>
    <description>Artelon Tissue Reinforcement</description>
    <arm_group_label>Artelon</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient has a clinically confirmed isolated chronic rupture or rerupture of the
             Achilles tendon.

          2. The patient has been informed about the study and signed the patient consent form.

          3. The patient reads, understands and is able to complete the study questionnaires in
             English.

        Exclusion Criteria:

          1. The patient has an ongoing infection of the soft tissues of the ankle.

          2. The patient has evidence of severe ankle arthritis.

          3. The patient has a multi-system or multi-limb trauma.

          4. The patient has a major medical condition that would affect quality of life and
             influence the results of the study.

          5. The patient is pregnant

          6. The patient is not expected to complete the study according to the investigation plan.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terrence M Philbin, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopedic Foot and Ankle Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Orthopedic Foot and Ankle Center</name>
      <address>
        <city>Westerville</city>
        <state>Ohio</state>
        <zip>43082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <results_first_submitted>May 8, 2015</results_first_submitted>
  <results_first_submitted_qc>May 8, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 27, 2015</results_first_posted>
  <last_update_submitted>June 29, 2015</last_update_submitted>
  <last_update_submitted_qc>June 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Achilles</keyword>
  <keyword>Rupture</keyword>
  <keyword>Tendon</keyword>
  <keyword>Artelon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Artelon</title>
          <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Artelon</title>
          <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54" lower_limit="38" upper_limit="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>The Foot Function Index (FFI) for Evaluation of Foot Pain and Disability</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Range of Motion, Strength and Calf Circumference</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion, Strength and Calf Circumference</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Evaluation of Treatment</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Evaluation of Treatment</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Return to Work and Previous Physical Activities</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Return to Work and Previous Physical Activities</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Evaluation Including Adverse Events</title>
        <time_frame>3 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Evaluation Including Adverse Events</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Range of Motion, Strength and Calf Circumference</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion, Strength and Calf Circumference</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Evaluation of Treatment</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Evaluation of Treatment</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Return to Work and Previous Physical Activities</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Return to Work and Previous Physical Activities</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Evaluation Including Adverse Events</title>
        <time_frame>6 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Evaluation Including Adverse Events</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>The American Orthopaedic Foot and Ankle Society (AOFAS) Clinical Rating System for Ankle-hindfoot</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patientschronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>General Measure of Health-related Quality of Life Using the EuroQoL (EQ-5D) Questionnaire</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Range of Motion, Strength and Calf Circumference</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion, Strength and Calf Circumference</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Evaluation of Treatment</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Evaluation of Treatment</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Return to Work and Previous Physical Activities</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Return to Work and Previous Physical Activities</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Evaluation Including Adverse Events</title>
        <time_frame>12 months</time_frame>
        <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
        <group_list>
          <group group_id="O1">
            <title>Open</title>
            <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Evaluation Including Adverse Events</title>
          <population>Data not analyzed as study was terminated due to sponsor bankruptcy.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Artelon</title>
          <description>This was an open, prospective study with an anticipated enrollment of 10 patients with chronic or repeat Achilles tendon rupture undergoing surgical repair augmented with Artelon® Tissue Reinforcement.
Artelon: Artelon Tissue Reinforcement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>C-difficile</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Increased tenderness over left peroneal and posterior tibial tendons</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The sample size is small due to the study being terminated early because of sponsor bankrupty,</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Terrence M. Philbin, DO</name_or_title>
      <organization>Orthopedic Foot and Ankle Center</organization>
      <phone>614-895-8747 ext 111</phone>
      <email>ofacresearch@orthofootankle.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

